Cargando…

Does Xpert® MTB/RIF assay give rifampicin resistance results without identified mutation? Review of cases from Addis Ababa, Ethiopia

BACKGROUND: Xpert® MTB/RIF assay is currently used in Ethiopia for the rapid diagnosis of Mycobacterium tuberculosis (MTB) and mutations that confer Rifampicin resistance. Rifampicin resistance is determined based on any mutation in the 81 bp of rpoB gene using five overlapping probes represented as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alemu, Ayinalem, Tadesse, Mengistu, Seid, Getachew, Mollalign, Helina, Eshetu, Kirubel, Sinshaw, Waganeh, Abebaw, Yeshiwork, Amare, Misikir, Dagne, Biniyam, Diriba, Getu, Yenew, Bazezew, Getu, Melak, Zerihun, Betselot
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993378/ https://www.ncbi.nlm.nih.gov/pubmed/32000702 http://dx.doi.org/10.1186/s12879-020-4817-2

Ejemplares similares

Detection of Mycobacterium tuberculosis and rifampicin resistance by Xpert® MTB/RIF assay among presumptive tuberculosis patients in Addis Ababa, Ethiopia from 2014 to 2021
por: Diriba, Getu, et al.
Publicado: (2022)

Effect of sputum quality and role of Xpert(®) MTB/ RIF assay for detection of smear-negative pulmonary tuberculosis in same-day diagnosis strategy in Addis Ababa, Ethiopia
por: Sinshaw, Waganeh, et al.
Publicado: (2022)

Monitoring quality indicators for the Xpert MTB/RIF molecular assay in Ethiopia
por: Kebede, Abebaw, et al.
Publicado: (2019)

Diagnostic accuracy of Truenat Tuberculosis and Rifampicin-Resistance assays in Addis Ababa, Ethiopia
por: Meaza, Abyot, et al.
Publicado: (2021)

Pre-extensively drug-resistant tuberculosis among multidrug-resistant tuberculosis patients in Ethiopia: a laboratory-based surveillance study
por: Diriba, Getu, et al.
Publicado: (2022)

Intestinal parasites co-infection and associated factors among active pulmonary tuberculosis patients in selected health centers, Addis Ababa, Ethiopia: unmatched case control study
por: Alemu, Ayinalem, et al.
Publicado: (2019)

The Epidemiology of first and second-line drug-resistance Mycobacterium tuberculosis complex common species: Evidence from selected TB treatment initiating centers in Ethiopia
por: Dagne, Biniyam, et al.
Publicado: (2021)

Quality assurance practices in tuberculosis diagnostic health facilities in Ethiopia
por: Abebaw, Yeshiwork, et al.
Publicado: (2022)

Surveillance of drug resistance tuberculosis based on reference laboratory data in Ethiopia
por: Diriba, Getu, et al.
Publicado: (2019)

The Simple One-Step (SOS) Stool Processing Method for Use with the Xpert MTB/RIF Assay for a Child-Friendly Diagnosis of Tuberculosis Closer to the Point of Care
por: de Haas, Petra, et al.
Publicado: (2021)

A smooth tubercle bacillus from Ethiopia phylogenetically close to the Mycobacterium tuberculosis complex
por: Yenew, Bazezew, et al.
Publicado: (2023)

Prevalence of tuberculosis, multidrug resistant tuberculosis and associated risk factors among smear negative presumptive pulmonary tuberculosis patients in Addis Ababa, Ethiopia
por: Sinshaw, Waganeh, et al.
Publicado: (2019)

Bacteriologically confirmed extrapulmonary tuberculosis and the associated risk factors among extrapulmonary tuberculosis suspected patients in Ethiopia: A systematic review and meta-analysis
por: Diriba, Getu, et al.
Publicado: (2022)

Epidemiology of extensively drug-resistant tuberculosis among patients with multidrug-resistant tuberculosis: A systematic review and meta-analysis
por: Diriba, Getu, et al.
Publicado: (2023)

Diagnostic accuracy of Xpert MTB/RIF assay and non-molecular methods for the diagnosis of tuberculosis lymphadenitis
por: Fantahun, Mengistu, et al.
Publicado: (2019)

Low Prevalence of Mycobacterium bovis in Tuberculosis Patients, Ethiopia
por: Getahun, Muluwork, et al.
Publicado: (2020)

Drug resistance and its risk factors among extrapulmonary tuberculosis in Ethiopia: A systematic review and meta-analysis
por: Diriba, Getu, et al.
Publicado: (2021)

Mycobacterial Lineages Associated with Drug Resistance in Patients with Extrapulmonary Tuberculosis in Addis Ababa, Ethiopia
por: Diriba, Getu, et al.
Publicado: (2021)

Molecular characterization and drug resistance patterns of Mycobacterium tuberculosis complex in extrapulmonary tuberculosis patients in Addis Ababa, Ethiopia
por: Diriba, Getu, et al.
Publicado: (2020)

Utility of line probe assay in detecting drug resistance and the associated mutations in patients with extrapulmonary tuberculosis in Addis Ababa, Ethiopia
por: Diriba, Getu, et al.
Publicado: (2022)

Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013)

The Effect of Long-Term HAART on the Incidence of Tuberculosis Among People Living with HIV in Addis Ababa, Ethiopia: A Matched Nested Case–Control Study
por: Alemu, Ayinalem, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019)

Tuberculosis in household contacts of tuberculosis patients in sub-Saharan African countries: A systematic review and meta-analysis
por: Seid, Getachew, et al.
Publicado: (2022)

Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)

Xpert MTB/RIF and Xpert MTB/RIF Ultra assays for active tuberculosis and rifampicin resistance in children
por: Kay, Alexander W, et al.
Publicado: (2020)

Drug sensitivity of clinical isolates of Mycobacterium tuberculosis and its association with bacterial genotype in the Somali region, Eastern Ethiopia
por: Worku, Getnet, et al.
Publicado: (2022)

Comparison of tests done, and tuberculosis cases detected by Xpert® MTB/RIF and Xpert® MTB/RIF-Ultra in Uganda
por: Kakinda, Michael, et al.
Publicado: (2022)

Comparison of Analytical Sensitivity (Limit of Detection) of Xpert MTB/RIF and Xpert MTB/RIF Ultra for Non-Sputum Specimens
por: Nielsen, Marisa C., et al.
Publicado: (2023)

The Magnitude of MTB and Rifampicin Resistance MTB Using Xpert-MTB/RIF Assay Among Tuberculosis Suspected Patients in Gedeo Zone, Southern Ethiopia
por: Diriba, Kuma, et al.
Publicado: (2021)

Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples
por: Meaza, Abyot, et al.
Publicado: (2017)

Incidence and predictors of extrapulmonary tuberculosis among people living with Human Immunodeficiency Virus in Addis Ababa, Ethiopia: A retrospective cohort study
por: Alemu, Ayinalem, et al.
Publicado: (2020)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for the diagnosis of tuberculous meningitis: a prospective, randomised, diagnostic accuracy study
por: Donovan, Joseph, et al.
Publicado: (2020)

Expedited diagnosis of pediatric tuberculosis using Truenat MTB-Rif Dx and GeneXpert MTB/RIF
por: Singh, Urvashi B., et al.
Publicado: (2023)

Incidence and predictors of acquired resistance to second-line antituberculosis drugs during the course of multi-drug resistant tuberculosis treatment: protocol for a systematic review and meta-analysis
por: Alemu, Ayinalem, et al.
Publicado: (2023)

Evaluation of Xpert MTB/RIF for the Diagnosis of Lymphatic Tuberculosis
por: Li, Hou-He, et al.
Publicado: (2020)

Xpert MTB/RIF Ultra versus Xpert MTB/RIF for diagnosis of tuberculous pleural effusion: A systematic review and comparative meta-analysis
por: Aggarwal, Ashutosh Nath, et al.
Publicado: (2022)

A glimpse into the genotype and clinical importance of non tuberculous mycobacteria among pulmonary tuberculosis patients: The case of Ethiopia
por: Alemayehu, Alem, et al.
Publicado: (2022)

Head-to-head comparison of the efficacy of Xpert MTB/RIF Ultra and Xpert MTB/RIF for the diagnosis of tuberculous pleurisy: A systematic review and meta-analysis
por: Yu, Wenfeng, et al.
Publicado: (2022)

Retrospective Diagnostic Accuracy Study of Abbott RealTime MTB against Xpert MTB/RIF Ultra and Xpert MTB/RIF for the Diagnosis of Pulmonary Tuberculosis and Susceptibility to Rifampin and Isoniazid Treatment
por: Howlett, Patrick, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_9oot95jmao2gheguqpbn9r10nc